Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001761047 | SCV001999856 | uncertain significance | not provided | 2024-12-04 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 33111992, 34515852) |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV004699459 | SCV005205145 | uncertain significance | not specified | 2024-06-17 | criteria provided, single submitter | clinical testing | Variant summary: CDH23 c.7128C>A (p.Asp2376Glu) results in a conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 249270 control chromosomes. c.7128C>A has been reported in the literature in individuals affected with Usher Syndrome and hearing loss (Brodie_2021, Florentine_2022). These data indicate that the variant may be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 33111992, 34515852). ClinVar contains an entry for this variant (Variation ID: 1310877). Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. |
Institute of Rare Diseases, |
RCV005052840 | SCV005687165 | likely pathogenic | Autosomal recessive nonsyndromic hearing loss 12 | 2025-01-09 | criteria provided, single submitter | research | PM3;PM5;PM2_Supporting;PP3 |